# A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.

> **NCT00141934** · PHASE2 · COMPLETED · sponsor: **Sosei** · enrollment: 232 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AD 452

## Key facts

- **NCT ID:** NCT00141934
- **Lead sponsor:** Sosei
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 232 (—)
- **Last updated:** 2007-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141934, "A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.". Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/clinical/NCT00141934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*